New
Conduit Pharmaceuticals Announces Advancements in Lupus Treatment Research
March 28, 2025
News
New
New Study Identifies Potential Biomarkers for Predicting Effectiveness of Mesenchymal Stem Cell Transplantation Therapy in People with Systemic Lupus Erythematosus
March 24, 2025
News
FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis
March 5, 2025
News
Conduit Pharmaceuticals Partners with Charles River Laboratories to Evaluate AZD1656 for Lupus Treatment
February 24, 2025
News
First Person Dosed with Investigational Therapy, ADI-001, for Treatment of Lupus Nephritis
November 21, 2024
News
ACR 2024 - New Guideline for the Screening, Treatment and Management of Lupus Nephritis
November 18, 2024
News
UPDATE: Seattle Children’s Now Enrolling Participants for First U.S. CAR T Cell Clinical Trial for Children with Systemic Lupus Erythematosus
November 12, 2024
News
UPDATE: Ventus Therapeutics Announces Positive Phase 1 Trial Results for Investigational Drug, VENT-03, for Lupus
November 4, 2024
News
GSK Set to Acquire CMG1A46 from Chimagen Biosciences
October 31, 2024
News
New Study Identifies Four Distinct Systemic Lupus Erythematosus Disease Progression Patterns
October 23, 2024
News
UPDATE: Kezar Life Sciences Terminates Phase 2b Study of Zetomipzomib for Lupus Nephritis Treatment
October 17, 2024
News
UPDATE: FDA Grants Cullinan Therapeutics Clearance for Application to Investigate CLN-978 for the Treatment of Systemic Lupus Erythematosus, Phase I Trial to Begin Soon
October 16, 2024
News